Find clinical trials for Triple Negative Breast Cancer in Cleveland, OH
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Triple Negative Breast Cancer trials near Cleveland, OH, USA:
immune response and demonstrate efficacy in patients with advanced triple-negative breast cancer.This study will ...
Phase 2
Cleveland, Ohio, United States and 5 other locations
This is a Phase 2, Multi-Cohort, Open-Label, Multi-Center Study. Cohort 1 will be a single-arm study of intratumoral tavokinogene telseplasmid (TAVO)...
Phase 2
Cleveland, Ohio, United States and 13 other locations
with stage I to III TNBC with residual invasive disease in the breast and/or axillary lymph nodes at surgical resection following neoadjuvan...
Phase 3
Cleveland, Ohio, United States and 357 other locations
(HCC), pancreatic ductal adenocarcinoma (PDAC), biliary tract cancers (BTC), esophageal squamous cell carcinoma (ESCC), triple negative...
Phase 1
Cleveland, Ohio, United States and 26 other locations
This is a Phase 1 open label sequential dose escalation and cohort expansion study evaluating the safety, tolerability and preliminary clinical activ...
Phase 1
Cleveland, Ohio, United States and 10 other locations
besides treating your disease.Participants will have solid tumor cancer that has spread through the body (metastatic) or cannot be removed w...
Phase 1
Cleveland, Ohio, United States and 22 other locations
The primary purpose of this study is to assess the safety and tolerability of AB598 when taken alone, and in combination with zimberelimab and standa...
Phase 1
Cleveland, Ohio, United States and 9 other locations
This is a first-in-human, open-label, multi-center, Phase 1, dose-escalation study with expansion cohorts to evaluate NM32-2668 for safety and immuno...
Phase 1
Cleveland, Ohio, United States and 4 other locations
This study is an an open-label Phase I trial of VT1021 in patients with advanced solid tumors. Patients must have recurrent or advanced cancer...
Phase 1
Cleveland, Ohio, United States and 11 other locations
The purpose of the trial is to evaluate the safety of acasunlimab (also known as GEN1046) as monotherapy and in combination therapies in patients wit...
Phase 1, Phase 2
Cleveland, Ohio, United States and 56 other locations
Clinical trials
Research sites
Resources
Legal